These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 31118805

  • 21. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
    Li J, Rao B, Yang J, Liu L, Huang M, Liu X, Cui G, Li C, Han Q, Yang H, Cui X, Sun R.
    Front Oncol; 2020; 10():769. PubMed ID: 32582536
    [Abstract] [Full Text] [Related]

  • 22. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N, Wang T, Li Q, Han F, Wang Z, Zhu R, Zhou J.
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [Abstract] [Full Text] [Related]

  • 23. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
    Wu X, Zhang X, Tao L, Dai X, Chen P.
    Biomed Res Int; 2020 May; 2020():2053902. PubMed ID: 32733931
    [Abstract] [Full Text] [Related]

  • 24. The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in hepatocellular carcinoma.
    Liu J, Sun G, Pan S, Qin M, Ouyang R, Li Z, Huang J.
    Bioengineered; 2020 Dec; 11(1):759-768. PubMed ID: 32631107
    [Abstract] [Full Text] [Related]

  • 25. Mettl3-m6A-YTHDF1 axis promotion of mitochondrial dysfunction in metabolic dysfunction-associated steatotic liver disease.
    Wang S, Zhang W, Wang Z, Liu Z, Yi X, Wu J.
    Cell Signal; 2024 Sep; 121():111303. PubMed ID: 39019337
    [Abstract] [Full Text] [Related]

  • 26. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A, Tuersunniyazi A, Meng X, Pei Y, Ji W, Feng Z, Jiang L, Wang Z, Kasimu M, Wang Y, Shi X.
    Front Genet; 2022 Sep; 13():872186. PubMed ID: 35937991
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
    Chang X, Lv YF, He J, Cao Y, Li CQ, Guo QN.
    J Hepatocell Carcinoma; 2021 Sep; 8():85-101. PubMed ID: 33738268
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma.
    Nakagawa N, Sonohara F, Tanaka K, Sunagawa Y, Inokawa Y, Takami H, Hayashi M, Yamada S, Kanda M, Tanaka C, Nakayama G, Koike M, Kodera Y.
    Oncol Lett; 2021 Jul; 22(1):538. PubMed ID: 34084217
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis.
    Qu N, Qin S, Zhang X, Bo X, Liu Z, Tan C, Wen G, Jiang H.
    BMC Cancer; 2020 Feb 28; 20(1):165. PubMed ID: 32111180
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhao X, Chen Y, Mao Q, Jiang X, Jiang W, Chen J, Xu W, Zhong L, Sun X.
    Cancer Biomark; 2018 Feb 28; 21(4):859-868. PubMed ID: 29439311
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X, Wang Z, Lu W, Miao L, Zhao Y.
    BMC Pulm Med; 2022 Aug 25; 22(1):324. PubMed ID: 36008805
    [Abstract] [Full Text] [Related]

  • 39. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
    Liu T, Sun L, Li ZZ, Yang K, Chen JM, Han XY, Qi LM, Zhou XG, Wang P.
    BMC Gastroenterol; 2023 May 11; 23(1):147. PubMed ID: 37170222
    [Abstract] [Full Text] [Related]

  • 40. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
    Pan J, Xu L, Pan H.
    Front Oncol; 2020 May 11; 10():1444. PubMed ID: 32974164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.